Monogram Orthopaedics
MGRM
MGRM was delisted on the 6th of October, 2025.
47 hedge funds and large institutions have $3.55M invested in Monogram Orthopaedics in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 1 closing their positions.
1,200% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 1
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
34% more funds holding
Funds holding: 35 → 47 (+12)
1% more capital invested
Capital invested by funds: $3.5M → $3.55M (+$51.6K)
0.2% more ownership
Funds ownership: 4.16% → 4.36% (+0.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFO
Fiduciary Family Office
Boca Raton,
Florida
|
+$68.8K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$56.5K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.5K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$38.1K |
| 5 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
+$30.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JPWM
Jamison Private Wealth Management
Milton,
Georgia
|
-$4.23K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.15K |
| 3 |
S
SignatureFD
Atlanta,
Georgia
|
-$703 |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$54 |
| 5 |
JP Morgan Chase
New York
|
-$5 |
MGRM Hedge Fund Activity: Q4 2024 in Review
47 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Monogram Orthopaedics (MGRM) for Q4 2024, worth a combined $3.55M — up 1.5% from $3.5M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new MGRM positions and 1 closed out — a net gain of 12 holders — while 11 added to existing stakes and 4 trimmed.
The largest buyer was Fiduciary Family Office, opening a new position worth an estimated $68.8K. The largest seller was Jamison Private Wealth Management, exiting entirely with an estimated $4.23K sold.
- 47 institutional investors held Monogram Orthopaedics (MGRM) as of Q4 2024, up from 35 in Q3 2024.
- Funds reported $3.55M of Monogram Orthopaedics stock for Q4 2024, up 1.5% quarter-over-quarter.
- 13 funds opened new Monogram Orthopaedics positions in Q4 2024 and 1 closed out, a net change of +12 holders.
- The largest Monogram Orthopaedics buyer in Q4 2024 was Fiduciary Family Office, an estimated $68.8K added.
- The largest Monogram Orthopaedics seller in Q4 2024 was Jamison Private Wealth Management, an estimated $4.23K sold.
Based on aggregated 13F filings for Q4 2024.